Specific active immunotherapy for melanoma

Ann Surg. 1979 Sep;190(3):366-72. doi: 10.1097/00000658-197909000-00012.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actuarial Analysis
  • BCG Vaccine / therapeutic use
  • Female
  • Humans
  • Immunotherapy*
  • Male
  • Melanoma / immunology
  • Melanoma / mortality
  • Melanoma / therapy*
  • Prognosis
  • Skin Neoplasms / immunology
  • Skin Neoplasms / mortality
  • Skin Neoplasms / therapy*

Substances

  • BCG Vaccine